Association of Alzheimer's disease and Chlamydophila pneumoniae

Journal of Infection

Volumn 56, Issue 6, 2008, Pages 423-431

  Stallings, Tiffany L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Chlamydia pneumoniae; Chlamydophila pneumoniae; Epidemiology; MMSE; NINCDS ADRDA

Indexed keywords

AMYLOID BETA PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ALZHEIMER DISEASE; AMNESIA; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; HIGH RISK POPULATION; HUMAN; IMMUNOFLUORESCENCE TEST; INCIDENCE; MINI MENTAL STATE EXAMINATION; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; SCORING SYSTEM; SENILE PLAQUE; SENSITIVITY AND SPECIFICITY;

ALZHEIMER DISEASE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; RISK FACTORS;

EID: 44649124786     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.03.013     Document Type: Review

References (69)

1. Graeber M.B. Alois Alzheimer (1864-1915). [Web page, Biography of Alois Alzheimer]. Available from: (2006). [accessed 02.07.07]
2. Illman D.L. A new bug that's full of surprises: Chlamydia pneumoniae. Pathbreakers: a century of excellence in science and technology at the University of Washington [Web page]. Available from: (1996). http://www.washington.edu/research/pathbreakers/1989a.html [accessed 26.06.07]
3. Kuo C.C., Jackson L.A., Campbell L.A., and Grayston J.T. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8 4 (1995) 451-461
4. Karin D.E., Everett B.R., and Andersen A.A. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 49 (1999) 26
5. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
6. Blennow K., de Leon M.J., and Zetterberg H. Alzheimer's disease. Lancet 368 9533 (2006) 387-403
7. Mattson M.P. Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 3 1 (2004) 105-120
8. Brain with Alzheimer's disease. 7/24/07; Available from: (2007). http://www.ahaf.org/alzdis/about/BrainAlzheimer.htm [accessed 09.11.07]
9. Munoz D.G., and Feldman H. Causes of Alzheimer's disease. CMAJ 162 1 (2000) 65-72
10. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 14 Suppl. K (1993) 57-61
11. Alzheimer's disease genetics: fact sheet. [Electronic] August 30, 2006; Available from: (2004). http://www.nia.nih.gov/Alzheimers/Publications/geneticsfs.htm [accessed 19.07.07]
12. Davidson E.A., and Robertson E.E. Alzheimer's disease with acne rosacea in one of identical twins. J Neurol Neurosurg Psychiatry 18 1 (1955) 72-77
13. Robinson S.R., Dobson C., and Lyons J. Challenges and directions for the pathogen hypothesis of Alzheimer's disease. Neurobiol Aging 25 5 (2004) 629-637
14. Gajdusek D.C. Slow virus diseases of the central nervous system. Am J Clin Pathol 56 3 (1971) 320-332
15. Renvoize E.B., Awad I.O., and Hambling M.H. A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. Age Ageing 16 5 (1987) 311-314
16. Yucesan C., and Sriram S. Chlamydia pneumoniae infection of the central nervous system. Curr Opin Neurol 14 3 (2001) 355-359
17. Kawas C., Gray S., Brookmeyer R., Fozard J., and Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 54 11 (2000) 2072-2077
18. Di Carlo A., Baldereschi M., Amaducci L., Lepore V., Bracco L., Maggi S., et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc 50 1 (2002) 41-48
19. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., et al. Incidence and etiology of dementia in a large elderly Italian population. Neurology 64 9 (2005) 1525-1530
20. Evans D.A., Bennett D.A., Wilson R.S., Bienias J.L., Morris M.C., Scherr P.A., et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol 60 2 (2003) 185-189
21. Brookmeyer R., Gray S., and Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88 9 (1998) 1337-1342
22. Bachman D.L., Wolf P.A., Linn R.T., Knoefel J.E., Cobb J.L., Belanger A.J., et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 43 3 Pt 1 (1993) 515-519
23. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60 8 (2003) 1119-1122
24. Evans D.A., Smith L.A., Scherr P.A., Albert M.S., Funkenstein H.H., and Hebert L.E. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol 134 4 (1991) 403-412
25. Hebert L.E., Scherr P.A., Beckett L.A., Albert M.S., Pilgrim D.M., Chown M.J., et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA 273 17 (1995) 1354-1359
26. Evans D.A. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q 68 2 (1990) 267-289
27. Hebert L.E., Beckett L.A., Scherr P.A., and Evans D.A. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 15 4 (2001) 169-173
28. Chicago Community Health Profile. Chicago Health and Health Systems Project. Available from: (2006). http://www.cityofchicago.org/health/profiles [accessed 19.06.07]
29. Tombaugh T.N., and McIntyre N.J. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40 9 (1992) 922-935
30. Hendrie H.C., Osuntokun B.O., Hall K.S., Ogunniyi A.O., Hui S.L., Unverzagt F.W., et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 152 10 (1995) 1485-1492
31. Sayetta R.B. Rates of senile dementia, Alzheimer's type, in the Baltimore Longitudinal Study. J Chronic Dis 39 4 (1986) 271-286
32. Blacker D., Albert M.S., Bassett S.S., Go R.C., Harrell L.E., and Folstein M.F. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol 51 12 (1994) 1198-1204
33. Kukull W.A., Larson E.B., Reifler B.V., Lampe T.H., Yerby M.S., and Hughes J.P. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology 40 9 (1990) 1364-1369
34. Andersen K., Nielsen H., Lolk A., Andersen J., Becker I., and Kragh-Sorensen P. Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study. Neurology 52 1 (1999) 85-90
35. Kukull W.A., Higdon R., Bowen J.D., McCormick W.C., Teri L., Schellenberg G.D., et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 59 11 (2002) 1737-1746
36. Breteler M.M., Claus J.J., van Duijn C.M., Launer L.J., and Hofman A. Epidemiology of Alzheimer's disease. Epidemiol Rev 14 (1992) 59-82
37. Pether J.V., Noah N.D., Lau Y.K., Taylor J.A., and Bowie J.C. An outbreak of psittacosis in a boys' boarding school. J Hyg (Lond) 92 3 (1984) 337-343
38. Pether J.V., Wang S.P., and Grayston J.T. Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis. Epidemiol Infect 103 2 (1989) 395-400
39. Karvonen M., Tuomilehto J., Naukkarinen A., and Saikku P. The prevalence and regional distribution of antibodies against Chlamydia pneumoniae (strain TWAR) in Finland in 1958. Int J Epidemiol 21 2 (1992) 391-398
40. Wagels G., Rasmussen S., and Timms P. Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene. J Clin Microbiol 32 11 (1994) 2820-2823
41. Kleemola M., Saikku P., Visakorpi R., Wang S.P., and Grayston J.T. Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis 157 2 (1988) 230-236
42. Thom D.H., Grayston J.T., Campbell L.A., Kuo C.C., Diwan V.K., and Wang S.P. Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infect Dis 13 10 (1994) 785-792
43. Thom D.H., Grayston J.T., Wang S.P., Kuo CC., and Altman J. Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol 132 2 (1990) 248-256
44. Ekman M.R., Grayston J.T., Visakorpi R., Kleemola M., Kuo C.C., and Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 17 3 (1993) 420-425
45. Grayston J.T. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 15 5 (1992) 757-761
46. Kinoshita J. Pathogens as a cause of Alzheimer's disease. Neurobiol Aging 25 5 (2004) 639-640
47. Koh W.P., Taylor M.B., Hughes K., Chew S.K., Fong C.W., Phoon M.C., et al. Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore. Int J Epidemiol 31 5 (2002) 1001-1007
48. Gnarpe H., Gnarpe J., and Lundback A. Evidence of 2 waves of Chlamydia pneumoniae infection in Gavle, Sweden, 1990-96. Scand J Infect Dis 31 1 (1999) 83-86
49. Ni A.P., Lin G.Y., Yang L., He H.Y., Huang C.W., Liu Z.J., et al. A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China. Scand J Infect Dis 28 6 (1996) 553-557
50. Kanamoto Y., Ouchi K., Mizui M., Ushio M., and Usui T. Prevalence of antibody to Chlamydia pneumoniae TWAR in japan. J Clin Microbiol 29 4 (1991) 816-818
51. Hyman C.L., Roblin P.M., Gaydos C.A., Quinn T.C., Schachter J., and Hammerschlag M.R. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 20 5 (1995) 1174-1178
52. Marton A., Karolyi A., and Szalka A. Prevalence of Chlamydia pneumoniae antibodies in Hungary. Eur J Clin Microbiol Infect Dis 11 2 (1992) 139-142
53. Theunissen H.J., Lemmens-den Toom N.A., Burggraaf A., Stolz E., and Michel M.F. Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols. Appl Environ Microbiol 59 8 (1993) 2589-2593
54. Saikku P.A. Cohen & Powderly: infectious diseases. 2nd ed. (2004), Mosby, An Imprint of Elsevier [chapter 236, Chlamydia]
55. Aldous M.B., Grayston J.T., Wang S.P., and Foy H.M. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis 166 3 (1992) 646-649
56. Lee K.J., Kwon S.J., Choi B.R., Bae S.M., Kishimoto T., Ando S., et al. Outbreak of respiratory tract infections on an islet in Korea: possible Chlamydia pneumoniae infection. Jpn J Infect Dis 59 5 (2006) 294-298
57. Wellinghausen N., Straube E., Freidank H., von Baum H., Marre R., and Essig A. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int J Med Microbiol 296 7 (2006) 485-491
58. Meijer A., Dagnelie C.F., De Jong J.C., De Vries A., Bestebroer T.M., Van Loon A.M., et al. Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices. Eur J Epidemiol 16 12 (2000) 1099-1106
59. Lieberman D., Schlaeffer F., and Porath A. Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home. Age Ageing 26 2 (1997) 69-75
60. Balin B.J., Gerard H.C., Arking E.J., Appelt D.M., Branigan P.J., Abrams J.T., et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187 1 (1998) 23-42
61. Taylor G.S., Vipond I.B., Paul I.D., Matthews S., Wilcock G.K., and Caul E.O. Failure to correlate C. pneumoniae with late onset Alzheimer's disease. Neurology 59 1 (2002) 142-143
62. Gerard H.C., Dreses-Werringloer U., Wildt K.S., Deka S., Oszust C., Balin B.J., et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol 48 3 (2006) 355-366
63. Gieffers J., Reusche E., Solbach W., and Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. J Clin Microbiol 38 2 (2000) 881-882
64. Gerard H.C., Wildt K.L., Whittum-Hudson J.A., Lai Z., Ager J., and Hudson A.P. The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog 39 1-2 (2005) 19-26
65. Nochlin D., Shaw C.M., Campbell L.A., and Kuo C.C. Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurology 53 8 (1999) 1888
66. Ring R.H., and Lyons J.M. Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J Clin Microbiol 38 7 (2000) 2591-2594
67. Bruunsgaard H., Ostergaard L., Andersen-Ranberg K., Jeune B., and Pedersen B.K. Proinflammatory cytokines, antibodies to Chlamydia pneumoniae and age-associated diseases in Danish centenarians: is there a link?. Scand J Infect Dis 34 7 (2002) 493-499
68. Yamamoto H., Watanabe T., Miyazaki A., Katagiri T., Idei T., Iguchi T., et al. High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia. J Am Geriatr Soc 53 4 (2005) 583-589
69. Stratton C.W., and Sriram S. Association of Chlamydia pneumoniae with central nervous system disease. Microbes Infect 5 13 (2003) 1249-1253